Scale Computing Delivers Hyperconverged Solution to South Africa Market with Axiz Partnership
Scale Computing, a market leader in hyperconverged solutions, announced a partnership with Axiz, a leading South African IT infrastructure and software distributor. The distributor will be reselling the Scale HC3 platform, combined with Lenovo servers, to create a simple to use and easy to deploy hyperconverged solution for the midmarket.
Through this new relationship, Axiz will become part of the Scale Partner Community, which provides enablement, tools and a range of incentives, alongside the opportunity to work closely with the Scale team on joint marketing activities.
Rather than treat storage, servers, virtualisation, and management as different data centre silos, the combined Scale Computing and Lenovo solution brings them together in one comprehensive system, automating overall management. With no extra virtualisation software to license and no external storage to buy, the solution offers lower out-of-pocket costs and radically simplifies the infrastructure needed to keep applications running.
With an extensive presence in South Africa and offices in strategic countries in southern and eastern Africa, Axiz carries a comprehensive range of products from over 50 of the world's leading IT brands. To kick-start the roll out of this new HC solution, the South African distributor has invested in demonstration clusters at its head office in Gauteng to highlight the benefits of Scale Computing's solution to partners and customers.
When the demonstration cluster is not being used commercially, the processing power is donated to numerous charities through www.worldcommunity.org. These include:
The Microbiome Immunity Project: The human microbiome is a collection of all of the bacteria that live inside our bodies and all of the genes they have. The 30 trillion bacteria that live in our own microbiome, are usually beneficial to humans but some are linked to diseases such as Type1 diabetes and Crohn's disease which are becoming more common across the globe.
Smash Childhood Cancer: Approximately 300,000 children globally are diagnosed with cancer every year and 80,000 die of the disease. The Smash Childhood Cancer project is an international team of researchers looking for drug candidates to treat childhood cancers.
Help Stop TB: Researchers from the University of Nottingham are partnering with the World Community Grid to take a close look at the bacteria that cause this deadly infectious disease to develop more effective treatments.
FightAIDS@Home Phase 1 and 2: This project is searching for drugs that can disable a key step in the lifecycle of the HIV virus and stop the onset of AIDS.
